Skip to main content
SRZN
NASDAQ Life Sciences

Major Investor Group's Stake Diluted to 29.3% Following Company Offerings

Analysis by Arik Shkolnikov
Sentiment info
Neutral
Importance info
7
Price
$28.15
Mkt Cap
$326.832M
52W Low
$5.9
52W High
$35
Market data snapshot near publication time

summarizeSummary

The Column Group III, a major investor group including a company director, reported a diluted ownership stake of 29.3% in Surrozen, Inc., reflecting the impact of recent company share issuances.


check_boxKey Events

  • Major Shareholder Update

    The Column Group III entities, including director Tim Kutzkey, now beneficially own 3,824,612 shares, representing 29.3% of Surrozen's common stock.

  • Dilution from Company Offerings

    The decrease in percentage ownership is attributed to dilution from the company's recent capital raising activities, including a $200 million shelf offering and a $50 million At-The-Market program launched in March 2026.

  • Significant Stake Maintained

    Despite the dilution, the group's holding remains substantial, valued at approximately $107.7 million based on the current stock price.


auto_awesomeAnalysis

This Schedule 13D/A updates the beneficial ownership of The Column Group III entities, including director Tim Kutzkey, to 29.3% of Surrozen's common stock. The filing explicitly states this percentage decrease is due to dilution from the company's recent sales of additional shares, such as the $200 million shelf offering and $50 million ATM program initiated in March 2026. While the group remains a significant shareholder, their relative influence has been reduced by these capital raises.

At the time of this filing, SRZN was trading at $28.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $326.8M. The 52-week trading range was $5.90 to $35.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed SRZN - Latest Insights

SRZN
May 18, 2026, 6:49 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
SRZN
May 06, 2026, 4:49 PM EDT
Source: Wiseek News
Importance Score:
9
SRZN
May 06, 2026, 4:38 PM EDT
Filing Type: 10-Q
Importance Score:
8
SRZN
Mar 30, 2026, 6:21 PM EDT
Filing Type: 424B5
Importance Score:
7
SRZN
Mar 25, 2026, 8:02 PM EDT
Filing Type: 4
Importance Score:
8
SRZN
Mar 23, 2026, 5:26 PM EDT
Filing Type: S-3
Importance Score:
9
SRZN
Mar 23, 2026, 4:30 PM EDT
Filing Type: 10-K
Importance Score:
9
SRZN
Mar 23, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
SRZN
Mar 23, 2026, 4:05 PM EDT
Source: Reuters
Importance Score:
8
SRZN
Mar 16, 2026, 7:05 PM EDT
Filing Type: 4
Importance Score:
7